Nuvigen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.60 Cr
as on 03-07-2024
- Revenue 485.56%
(FY 2023)
- Profit 115.38%
(FY 2023)
- Ebitda 100.00%
(FY 2023)
- Net Worth 36.71%
(FY 2023)
- Total Assets 1719.81%
(FY 2023)
About Nuvigen Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.60 Cr.
Ajay Madhavan, Naresh Chowhan, and Kalpesh Chowhan serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC311289
- Company No.
311289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Bhiwandi, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nuvigen Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Madhavan  | Director | 28-Jun-2018 | Current |
| Naresh Chowhan | Director | 23-Jan-2023 | Current |
| Kalpesh Chowhan | Director | 23-Jan-2023 | Current |
Financial Performance of Nuvigen Life Sciences.
Nuvigen Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 485.56% increase. The company also saw a substantial improvement in profitability, with a 115.38% increase in profit. The company's net worth Soared by an impressive increase of 36.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuvigen Life Sciences?
In 2023, Nuvigen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chowhan Ventures Private LimitedActive 17 years 11 monthsNaresh Chowhan and Kalpesh Chowhan are mutual person
Vhs Logitech Private LimitedActive 7 years 10 monthsNaresh Chowhan and Kalpesh Chowhan are mutual person
Techgix Innovations Private LimitedActive 1 year 9 monthsNaresh Chowhan and Kalpesh Chowhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 Nov 2022 | ₹3.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 15 Oct 2022 | ₹6.00 M | Open |
How Many Employees Work at Nuvigen Life Sciences?
Unlock and access historical data on people associated with Nuvigen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuvigen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvigen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
